The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Imodium Plus 2 mg/125 mg Tablets



JNTL Consumer Health I (Ireland) LimitedPA23490/030/001

Main Information

Trade NameImodium Plus 2 mg/125 mg Tablets
Active SubstancesLoperamide hydrochloride
Simeticone
Dosage FormTablet
Licence HolderJNTL Consumer Health I (Ireland) Limited
Licence NumberPA23490/030/001

Group Information

ATC CodeA07DA Antipropulsives
A07DA53 loperamide, combinations

Status

License statusAuthorised
Licence Issued20/04/2007
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back